Request for Covid-19 Impact Assessment of this Report
The United States Aminoglycoside Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Aminoglycoside Drug market, reaching US$ million by the year 2028. As for the Europe Aminoglycoside Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Aminoglycoside Drug players cover Jemicare, Teva, Novartis Pharmaceuticals, and Fangyuan-pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Aminoglycoside Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Neomycin
Tobramycin
Gentamicin
Amikacin
Etimicin
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Retail Pharmacy
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Jemicare
Teva
Novartis Pharmaceuticals
Fangyuan-pharma
Aike Pharmaceutical
Cipla
Pfizer
FRESENIUS KABI
Sun Pharma
Hikma
Lannett Company
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Aminoglycoside Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Aminoglycoside Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Aminoglycoside Drug by Country/Region, 2017, 2022 & 2028
2.2 Aminoglycoside Drug Segment by Type
2.2.1 Neomycin
2.2.2 Tobramycin
2.2.3 Gentamicin
2.2.4 Amikacin
2.2.5 Etimicin
2.2.6 Others
2.3 Aminoglycoside Drug Sales by Type
2.3.1 Global Aminoglycoside Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Aminoglycoside Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Aminoglycoside Drug Sale Price by Type (2017-2022)
2.4 Aminoglycoside Drug Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Other
2.5 Aminoglycoside Drug Sales by Application
2.5.1 Global Aminoglycoside Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Aminoglycoside Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Aminoglycoside Drug Sale Price by Application (2017-2022)
3 Global Aminoglycoside Drug by Company
3.1 Global Aminoglycoside Drug Breakdown Data by Company
3.1.1 Global Aminoglycoside Drug Annual Sales by Company (2020-2022)
3.1.2 Global Aminoglycoside Drug Sales Market Share by Company (2020-2022)
3.2 Global Aminoglycoside Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Aminoglycoside Drug Revenue by Company (2020-2022)
3.2.2 Global Aminoglycoside Drug Revenue Market Share by Company (2020-2022)
3.3 Global Aminoglycoside Drug Sale Price by Company
3.4 Key Manufacturers Aminoglycoside Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Aminoglycoside Drug Product Location Distribution
3.4.2 Players Aminoglycoside Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Aminoglycoside Drug by Geographic Region
4.1 World Historic Aminoglycoside Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Aminoglycoside Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Aminoglycoside Drug Annual Revenue by Geographic Region
4.2 World Historic Aminoglycoside Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Aminoglycoside Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Aminoglycoside Drug Annual Revenue by Country/Region
4.3 Americas Aminoglycoside Drug Sales Growth
4.4 APAC Aminoglycoside Drug Sales Growth
4.5 Europe Aminoglycoside Drug Sales Growth
4.6 Middle East & Africa Aminoglycoside Drug Sales Growth
5 Americas
5.1 Americas Aminoglycoside Drug Sales by Country
5.1.1 Americas Aminoglycoside Drug Sales by Country (2017-2022)
5.1.2 Americas Aminoglycoside Drug Revenue by Country (2017-2022)
5.2 Americas Aminoglycoside Drug Sales by Type
5.3 Americas Aminoglycoside Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Aminoglycoside Drug Sales by Region
6.1.1 APAC Aminoglycoside Drug Sales by Region (2017-2022)
6.1.2 APAC Aminoglycoside Drug Revenue by Region (2017-2022)
6.2 APAC Aminoglycoside Drug Sales by Type
6.3 APAC Aminoglycoside Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Aminoglycoside Drug by Country
7.1.1 Europe Aminoglycoside Drug Sales by Country (2017-2022)
7.1.2 Europe Aminoglycoside Drug Revenue by Country (2017-2022)
7.2 Europe Aminoglycoside Drug Sales by Type
7.3 Europe Aminoglycoside Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Aminoglycoside Drug by Country
8.1.1 Middle East & Africa Aminoglycoside Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Aminoglycoside Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Aminoglycoside Drug Sales by Type
8.3 Middle East & Africa Aminoglycoside Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Aminoglycoside Drug
10.3 Manufacturing Process Analysis of Aminoglycoside Drug
10.4 Industry Chain Structure of Aminoglycoside Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Aminoglycoside Drug Distributors
11.3 Aminoglycoside Drug Customer
12 World Forecast Review for Aminoglycoside Drug by Geographic Region
12.1 Global Aminoglycoside Drug Market Size Forecast by Region
12.1.1 Global Aminoglycoside Drug Forecast by Region (2023-2028)
12.1.2 Global Aminoglycoside Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Aminoglycoside Drug Forecast by Type
12.7 Global Aminoglycoside Drug Forecast by Application
13 Key Players Analysis
13.1 Jemicare
13.1.1 Jemicare Company Information
13.1.2 Jemicare Aminoglycoside Drug Product Offered
13.1.3 Jemicare Aminoglycoside Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Jemicare Main Business Overview
13.1.5 Jemicare Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Aminoglycoside Drug Product Offered
13.2.3 Teva Aminoglycoside Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Novartis Pharmaceuticals
13.3.1 Novartis Pharmaceuticals Company Information
13.3.2 Novartis Pharmaceuticals Aminoglycoside Drug Product Offered
13.3.3 Novartis Pharmaceuticals Aminoglycoside Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Novartis Pharmaceuticals Main Business Overview
13.3.5 Novartis Pharmaceuticals Latest Developments
13.4 Fangyuan-pharma
13.4.1 Fangyuan-pharma Company Information
13.4.2 Fangyuan-pharma Aminoglycoside Drug Product Offered
13.4.3 Fangyuan-pharma Aminoglycoside Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Fangyuan-pharma Main Business Overview
13.4.5 Fangyuan-pharma Latest Developments
13.5 Aike Pharmaceutical
13.5.1 Aike Pharmaceutical Company Information
13.5.2 Aike Pharmaceutical Aminoglycoside Drug Product Offered
13.5.3 Aike Pharmaceutical Aminoglycoside Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Aike Pharmaceutical Main Business Overview
13.5.5 Aike Pharmaceutical Latest Developments
13.6 Cipla
13.6.1 Cipla Company Information
13.6.2 Cipla Aminoglycoside Drug Product Offered
13.6.3 Cipla Aminoglycoside Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Cipla Main Business Overview
13.6.5 Cipla Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Aminoglycoside Drug Product Offered
13.7.3 Pfizer Aminoglycoside Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 FRESENIUS KABI
13.8.1 FRESENIUS KABI Company Information
13.8.2 FRESENIUS KABI Aminoglycoside Drug Product Offered
13.8.3 FRESENIUS KABI Aminoglycoside Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 FRESENIUS KABI Main Business Overview
13.8.5 FRESENIUS KABI Latest Developments
13.9 Sun Pharma
13.9.1 Sun Pharma Company Information
13.9.2 Sun Pharma Aminoglycoside Drug Product Offered
13.9.3 Sun Pharma Aminoglycoside Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Sun Pharma Main Business Overview
13.9.5 Sun Pharma Latest Developments
13.10 Hikma
13.10.1 Hikma Company Information
13.10.2 Hikma Aminoglycoside Drug Product Offered
13.10.3 Hikma Aminoglycoside Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Hikma Main Business Overview
13.10.5 Hikma Latest Developments
13.11 Lannett Company
13.11.1 Lannett Company Company Information
13.11.2 Lannett Company Aminoglycoside Drug Product Offered
13.11.3 Lannett Company Aminoglycoside Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Lannett Company Main Business Overview
13.11.5 Lannett Company Latest Developments
14 Research Findings and Conclusion
Table 1. Aminoglycoside Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Aminoglycoside Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Neomycin
Table 4. Major Players of Tobramycin
Table 5. Major Players of Gentamicin
Table 6. Major Players of Amikacin
Table 7. Major Players of Etimicin
Table 8. Major Players of Others
Table 9. Global Aminoglycoside Drug Sales by Type (2017-2022) & (Units)
Table 10. Global Aminoglycoside Drug Sales Market Share by Type (2017-2022)
Table 11. Global Aminoglycoside Drug Revenue by Type (2017-2022) & ($ million)
Table 12. Global Aminoglycoside Drug Revenue Market Share by Type (2017-2022)
Table 13. Global Aminoglycoside Drug Sale Price by Type (2017-2022) & (US$/Unit)
Table 14. Global Aminoglycoside Drug Sales by Application (2017-2022) & (Units)
Table 15. Global Aminoglycoside Drug Sales Market Share by Application (2017-2022)
Table 16. Global Aminoglycoside Drug Revenue by Application (2017-2022)
Table 17. Global Aminoglycoside Drug Revenue Market Share by Application (2017-2022)
Table 18. Global Aminoglycoside Drug Sale Price by Application (2017-2022) & (US$/Unit)
Table 19. Global Aminoglycoside Drug Sales by Company (2020-2022) & (Units)
Table 20. Global Aminoglycoside Drug Sales Market Share by Company (2020-2022)
Table 21. Global Aminoglycoside Drug Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Aminoglycoside Drug Revenue Market Share by Company (2020-2022)
Table 23. Global Aminoglycoside Drug Sale Price by Company (2020-2022) & (US$/Unit)
Table 24. Key Manufacturers Aminoglycoside Drug Producing Area Distribution and Sales Area
Table 25. Players Aminoglycoside Drug Products Offered
Table 26. Aminoglycoside Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Aminoglycoside Drug Sales by Geographic Region (2017-2022) & (Units)
Table 30. Global Aminoglycoside Drug Sales Market Share Geographic Region (2017-2022)
Table 31. Global Aminoglycoside Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Aminoglycoside Drug Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Aminoglycoside Drug Sales by Country/Region (2017-2022) & (Units)
Table 34. Global Aminoglycoside Drug Sales Market Share by Country/Region (2017-2022)
Table 35. Global Aminoglycoside Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Aminoglycoside Drug Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Aminoglycoside Drug Sales by Country (2017-2022) & (Units)
Table 38. Americas Aminoglycoside Drug Sales Market Share by Country (2017-2022)
Table 39. Americas Aminoglycoside Drug Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Aminoglycoside Drug Revenue Market Share by Country (2017-2022)
Table 41. Americas Aminoglycoside Drug Sales by Type (2017-2022) & (Units)
Table 42. Americas Aminoglycoside Drug Sales Market Share by Type (2017-2022)
Table 43. Americas Aminoglycoside Drug Sales by Application (2017-2022) & (Units)
Table 44. Americas Aminoglycoside Drug Sales Market Share by Application (2017-2022)
Table 45. APAC Aminoglycoside Drug Sales by Region (2017-2022) & (Units)
Table 46. APAC Aminoglycoside Drug Sales Market Share by Region (2017-2022)
Table 47. APAC Aminoglycoside Drug Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Aminoglycoside Drug Revenue Market Share by Region (2017-2022)
Table 49. APAC Aminoglycoside Drug Sales by Type (2017-2022) & (Units)
Table 50. APAC Aminoglycoside Drug Sales Market Share by Type (2017-2022)
Table 51. APAC Aminoglycoside Drug Sales by Application (2017-2022) & (Units)
Table 52. APAC Aminoglycoside Drug Sales Market Share by Application (2017-2022)
Table 53. Europe Aminoglycoside Drug Sales by Country (2017-2022) & (Units)
Table 54. Europe Aminoglycoside Drug Sales Market Share by Country (2017-2022)
Table 55. Europe Aminoglycoside Drug Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Aminoglycoside Drug Revenue Market Share by Country (2017-2022)
Table 57. Europe Aminoglycoside Drug Sales by Type (2017-2022) & (Units)
Table 58. Europe Aminoglycoside Drug Sales Market Share by Type (2017-2022)
Table 59. Europe Aminoglycoside Drug Sales by Application (2017-2022) & (Units)
Table 60. Europe Aminoglycoside Drug Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Aminoglycoside Drug Sales by Country (2017-2022) & (Units)
Table 62. Middle East & Africa Aminoglycoside Drug Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Aminoglycoside Drug Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Aminoglycoside Drug Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Aminoglycoside Drug Sales by Type (2017-2022) & (Units)
Table 66. Middle East & Africa Aminoglycoside Drug Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Aminoglycoside Drug Sales by Application (2017-2022) & (Units)
Table 68. Middle East & Africa Aminoglycoside Drug Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Aminoglycoside Drug
Table 70. Key Market Challenges & Risks of Aminoglycoside Drug
Table 71. Key Industry Trends of Aminoglycoside Drug
Table 72. Aminoglycoside Drug Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Aminoglycoside Drug Distributors List
Table 75. Aminoglycoside Drug Customer List
Table 76. Global Aminoglycoside Drug Sales Forecast by Region (2023-2028) & (Units)
Table 77. Global Aminoglycoside Drug Sales Market Forecast by Region
Table 78. Global Aminoglycoside Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Aminoglycoside Drug Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Aminoglycoside Drug Sales Forecast by Country (2023-2028) & (Units)
Table 81. Americas Aminoglycoside Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Aminoglycoside Drug Sales Forecast by Region (2023-2028) & (Units)
Table 83. APAC Aminoglycoside Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Aminoglycoside Drug Sales Forecast by Country (2023-2028) & (Units)
Table 85. Europe Aminoglycoside Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Aminoglycoside Drug Sales Forecast by Country (2023-2028) & (Units)
Table 87. Middle East & Africa Aminoglycoside Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Aminoglycoside Drug Sales Forecast by Type (2023-2028) & (Units)
Table 89. Global Aminoglycoside Drug Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Aminoglycoside Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Aminoglycoside Drug Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Aminoglycoside Drug Sales Forecast by Application (2023-2028) & (Units)
Table 93. Global Aminoglycoside Drug Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Aminoglycoside Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Aminoglycoside Drug Revenue Market Share Forecast by Application (2023-2028)
Table 96. Jemicare Basic Information, Aminoglycoside Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. Jemicare Aminoglycoside Drug Product Offered
Table 98. Jemicare Aminoglycoside Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 99. Jemicare Main Business
Table 100. Jemicare Latest Developments
Table 101. Teva Basic Information, Aminoglycoside Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. Teva Aminoglycoside Drug Product Offered
Table 103. Teva Aminoglycoside Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 104. Teva Main Business
Table 105. Teva Latest Developments
Table 106. Novartis Pharmaceuticals Basic Information, Aminoglycoside Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Novartis Pharmaceuticals Aminoglycoside Drug Product Offered
Table 108. Novartis Pharmaceuticals Aminoglycoside Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 109. Novartis Pharmaceuticals Main Business
Table 110. Novartis Pharmaceuticals Latest Developments
Table 111. Fangyuan-pharma Basic Information, Aminoglycoside Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. Fangyuan-pharma Aminoglycoside Drug Product Offered
Table 113. Fangyuan-pharma Aminoglycoside Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 114. Fangyuan-pharma Main Business
Table 115. Fangyuan-pharma Latest Developments
Table 116. Aike Pharmaceutical Basic Information, Aminoglycoside Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. Aike Pharmaceutical Aminoglycoside Drug Product Offered
Table 118. Aike Pharmaceutical Aminoglycoside Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 119. Aike Pharmaceutical Main Business
Table 120. Aike Pharmaceutical Latest Developments
Table 121. Cipla Basic Information, Aminoglycoside Drug Manufacturing Base, Sales Area and Its Competitors
Table 122. Cipla Aminoglycoside Drug Product Offered
Table 123. Cipla Aminoglycoside Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 124. Cipla Main Business
Table 125. Cipla Latest Developments
Table 126. Pfizer Basic Information, Aminoglycoside Drug Manufacturing Base, Sales Area and Its Competitors
Table 127. Pfizer Aminoglycoside Drug Product Offered
Table 128. Pfizer Aminoglycoside Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 129. Pfizer Main Business
Table 130. Pfizer Latest Developments
Table 131. FRESENIUS KABI Basic Information, Aminoglycoside Drug Manufacturing Base, Sales Area and Its Competitors
Table 132. FRESENIUS KABI Aminoglycoside Drug Product Offered
Table 133. FRESENIUS KABI Aminoglycoside Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 134. FRESENIUS KABI Main Business
Table 135. FRESENIUS KABI Latest Developments
Table 136. Sun Pharma Basic Information, Aminoglycoside Drug Manufacturing Base, Sales Area and Its Competitors
Table 137. Sun Pharma Aminoglycoside Drug Product Offered
Table 138. Sun Pharma Aminoglycoside Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 139. Sun Pharma Main Business
Table 140. Sun Pharma Latest Developments
Table 141. Hikma Basic Information, Aminoglycoside Drug Manufacturing Base, Sales Area and Its Competitors
Table 142. Hikma Aminoglycoside Drug Product Offered
Table 143. Hikma Aminoglycoside Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 144. Hikma Main Business
Table 145. Hikma Latest Developments
Table 146. Lannett Company Basic Information, Aminoglycoside Drug Manufacturing Base, Sales Area and Its Competitors
Table 147. Lannett Company Aminoglycoside Drug Product Offered
Table 148. Lannett Company Aminoglycoside Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 149. Lannett Company Main Business
Table 150. Lannett Company Latest Developments
List of Figures
Figure 1. Picture of Aminoglycoside Drug
Figure 2. Aminoglycoside Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Aminoglycoside Drug Sales Growth Rate 2017-2028 (Units)
Figure 7. Global Aminoglycoside Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Aminoglycoside Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Neomycin
Figure 10. Product Picture of Tobramycin
Figure 11. Product Picture of Gentamicin
Figure 12. Product Picture of Amikacin
Figure 13. Product Picture of Etimicin
Figure 14. Product Picture of Others
Figure 15. Global Aminoglycoside Drug Sales Market Share by Type in 2021
Figure 16. Global Aminoglycoside Drug Revenue Market Share by Type (2017-2022)
Figure 17. Aminoglycoside Drug Consumed in Hospital
Figure 18. Global Aminoglycoside Drug Market: Hospital (2017-2022) & (Units)
Figure 19. Aminoglycoside Drug Consumed in Retail Pharmacy
Figure 20. Global Aminoglycoside Drug Market: Retail Pharmacy (2017-2022) & (Units)
Figure 21. Aminoglycoside Drug Consumed in Other
Figure 22. Global Aminoglycoside Drug Market: Other (2017-2022) & (Units)
Figure 23. Global Aminoglycoside Drug Sales Market Share by Application (2017-2022)
Figure 24. Global Aminoglycoside Drug Revenue Market Share by Application in 2021
Figure 25. Aminoglycoside Drug Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Aminoglycoside Drug Revenue Market Share by Company in 2021
Figure 27. Global Aminoglycoside Drug Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Aminoglycoside Drug Revenue Market Share by Geographic Region in 2021
Figure 29. Global Aminoglycoside Drug Sales Market Share by Region (2017-2022)
Figure 30. Global Aminoglycoside Drug Revenue Market Share by Country/Region in 2021
Figure 31. Americas Aminoglycoside Drug Sales 2017-2022 (Units)
Figure 32. Americas Aminoglycoside Drug Revenue 2017-2022 ($ Millions)
Figure 33. APAC Aminoglycoside Drug Sales 2017-2022 (Units)
Figure 34. APAC Aminoglycoside Drug Revenue 2017-2022 ($ Millions)
Figure 35. Europe Aminoglycoside Drug Sales 2017-2022 (Units)
Figure 36. Europe Aminoglycoside Drug Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Aminoglycoside Drug Sales 2017-2022 (Units)
Figure 38. Middle East & Africa Aminoglycoside Drug Revenue 2017-2022 ($ Millions)
Figure 39. Americas Aminoglycoside Drug Sales Market Share by Country in 2021
Figure 40. Americas Aminoglycoside Drug Revenue Market Share by Country in 2021
Figure 41. United States Aminoglycoside Drug Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Aminoglycoside Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Aminoglycoside Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Aminoglycoside Drug Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Aminoglycoside Drug Sales Market Share by Region in 2021
Figure 46. APAC Aminoglycoside Drug Revenue Market Share by Regions in 2021
Figure 47. China Aminoglycoside Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Aminoglycoside Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Aminoglycoside Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Aminoglycoside Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Aminoglycoside Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Aminoglycoside Drug Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Aminoglycoside Drug Sales Market Share by Country in 2021
Figure 54. Europe Aminoglycoside Drug Revenue Market Share by Country in 2021
Figure 55. Germany Aminoglycoside Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Aminoglycoside Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Aminoglycoside Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Aminoglycoside Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Aminoglycoside Drug Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Aminoglycoside Drug Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Aminoglycoside Drug Revenue Market Share by Country in 2021
Figure 62. Egypt Aminoglycoside Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Aminoglycoside Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Aminoglycoside Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Aminoglycoside Drug Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Aminoglycoside Drug Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Aminoglycoside Drug in 2021
Figure 68. Manufacturing Process Analysis of Aminoglycoside Drug
Figure 69. Industry Chain Structure of Aminoglycoside Drug
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...